Page last updated: 2024-10-17

n(g),n(g')-dimethyl-l-arginine and Hematologic Malignancies

n(g),n(g')-dimethyl-l-arginine has been researched along with Hematologic Malignancies in 1 studies

N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine

Research Excerpts

ExcerptRelevanceReference
"Asymmetric dimethylarginine (ADMA) is a product of protein hydrolysis and an endogenous competitive inhibitor of nitric oxide synthase."1.35Asymmetric dimethylarginine in hematological malignancies: a preliminary study. ( Andrzejak, R; Antonowicz-Juchniewicz, J; Chachaj, A; Dzietczenia, J; Kuliczkowski, K; Mazur, G; Szuba, A; Wróbel, T, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Szuba, A1
Chachaj, A1
Wróbel, T1
Dzietczenia, J1
Mazur, G1
Antonowicz-Juchniewicz, J1
Kuliczkowski, K1
Andrzejak, R1

Other Studies

1 other study available for n(g),n(g')-dimethyl-l-arginine and Hematologic Malignancies

ArticleYear
Asymmetric dimethylarginine in hematological malignancies: a preliminary study.
    Leukemia & lymphoma, 2008, Volume: 49, Issue:12

    Topics: Adult; Aged; Arginine; Biomarkers, Tumor; Case-Control Studies; Female; Hematologic Neoplasms; Human

2008